Response to Comments: MolDX DecisionDx-Melanoma

This document (Policy ID A56496) is a response to comments on the proposed MolDX DecisionDx‑Melanoma LCD (DL38016), noting the comment period (Feb 13–Mar 29, 2019), the notice period (May 9–Jun 23, 2019), and that the LCD became final on June 24, 2019. The provided excerpt contains no clinical coverage criteria, indications, limitations, documentation requirements, or frequency limits. Review the full LCD DL38016 for specific coverage and claim documentation requirements.